| Literature DB >> 31408238 |
Giuliana E Salazar-Noratto1,2, Guotian Luo1,2, Cyprien Denoeud1,2, Mathilde Padrona1,2, Adrien Moya3,4, Morad Bensidhoum1,2, Rena Bizios5, Esther Potier1,2, Delphine Logeart-Avramoglou1,2, Hervé Petite1,2.
Abstract
In tissue engineering and regenerative medicine, stem cell-specifically, mesenchymal stromal/stem cells (MSCs)-therapies have fallen short of their initial promise and hype. The observed marginal, to no benefit, success in several applications has been attributed primarily to poor cell survival and engraftment at transplantation sites. MSCs have a metabolism that is flexible enough to enable them to fulfill their various cellular functions and remarkably sensitive to different cellular and environmental cues. At the transplantation sites, MSCs experience hostile environments devoid or, at the very least, severely depleted of oxygen and nutrients. The impact of this particular setting on MSC metabolism ultimately affects their survival and function. In order to develop the next generation of cell-delivery materials and methods, scientists must have a better understanding of the metabolic switches MSCs experience upon transplantation. By designing treatment strategies with cell metabolism in mind, scientists may improve survival and the overall therapeutic potential of MSCs. Here, we provide a comprehensive review of plausible metabolic switches in response to implantation and of the various strategies currently used to leverage MSC metabolism to improve stem cell-based therapeutics. ©AlphaMed Press 2019.Entities:
Keywords: bioenergetics; cell delivery and transplantation; cell survival; cell-based therapies; mesenchymal stem cells; metabolism; multipotent stromal cells; skeletal stem cells; tissue engineering and regenerative medicine
Mesh:
Year: 2019 PMID: 31408238 DOI: 10.1002/stem.3079
Source DB: PubMed Journal: Stem Cells ISSN: 1066-5099 Impact factor: 6.277